Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.

Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, Ernst M, Ravn P, Duarte R, Morais C, Hoffmann M, Schoch OD, Dominguez J, Latorre I, Ruhwald M.

Tuberculosis (Edinb). 2016 May;98:7-12. doi: 10.1016/j.tube.2015.04.013. Epub 2015 May 15.

PMID:
27156612
2.

Predictors of body composition changes during tuberculosis treatment in Mwanza, Tanzania.

PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Magnussen P, Changalucha J, Andersen AB, Wells JC, Friis H.

Eur J Clin Nutr. 2015 Oct;69(10):1125-32. doi: 10.1038/ejcn.2015.37. Epub 2015 Apr 1.

PMID:
25828630
3.

False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.

de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Dominguez J, Eyuboglu F, Ghanem M, Goletti D, Dilektasli AG, Guglielmetti L, Koh WJ, Latorre I, Losi M, Polanova M, Ravn P, Ringshausen FC, Rumetshofer R, de Souza-Galvão ML, Thijsen S, Bothamley G, Bossink A; TBNET.

Eur Respir J. 2015 Jan;45(1):279-83. doi: 10.1183/09031936.00120214. Epub 2014 Oct 30. No abstract available.

4.

Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania.

Stavrum R, PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Krarup H, Aabye MG, Changalucha J, Friis H, Andersen AB, Grewal HM.

BMC Infect Dis. 2014 Jun 5;14:309. doi: 10.1186/1471-2334-14-309.

5.

Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.

Faurholt-Jepsen D, Aabye MG, Jensen AV, Range N, Praygod G, Jeremiah K, Changalucha J, Faurholt-Jepsen M, Jensen L, Jensen SM, Krarup H, Ravn P, Friis H, Andersen AB.

Scand J Infect Dis. 2014 May;46(5):384-91. doi: 10.3109/00365548.2014.885657. Epub 2014 Mar 12.

PMID:
24621055
6.

The association between conventional risk factors and diabetes is weak among urban Tanzanians.

Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Ritz C, Christensen DL, Jørgensen ME, Andersen AB, Friis H.

Diabetes Care. 2014;37(1):e5-6. doi: 10.2337/dc13-1905. No abstract available.

PMID:
24356608
7.

The use of combined heart rate response and accelerometry to assess the level and predictors of physical activity in tuberculosis patients in Tanzania.

Faurholt-Jepsen M, Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Aabye MG, Changalucha J, Krarup H, Christensen DL, Andersen AB, Brage S, Friis H.

Epidemiol Infect. 2014 Jun;142(6):1334-42. doi: 10.1017/S0950268813002070. Epub 2013 Sep 6.

PMID:
24007696
8.

The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania.

Jensen AV, Jensen L, Faurholt-Jepsen D, Aabye MG, Praygod G, Kidola J, Faurholt-Jepsen M, Changalucha J, Range N, Krarup H, Friis H, Andersen AB.

PLoS One. 2013 May 21;8(5):e64008. doi: 10.1371/journal.pone.0064008. Print 2013.

9.

Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania.

Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Grewal HM, Martinussen T, Krarup H, Witte DR, Andersen AB, Friis H.

Trop Med Int Health. 2013 Jul;18(7):822-9. doi: 10.1111/tmi.12120. Epub 2013 May 6.

10.

Sex, smoking, and socioeconomic status are associated with body composition among tuberculosis patients in a deuterium dilution cross-sectional study in Mwanza, Tanzania.

PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Magnussen P, Changalucha J, Andersen AB, Wells JC, Friis H.

J Nutr. 2013 May;143(5):735-41. doi: 10.3945/jn.112.168997. Epub 2013 Mar 20.

PMID:
23514764
11.

Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth.

Haedersdal S, Salvig JD, Aabye M, Thorball CW, Ruhwald M, Ladelund S, Eugen-Olsen J, Secher NJ.

Inflammation. 2013 Aug;36(4):907-13. doi: 10.1007/s10753-013-9619-x.

PMID:
23471783
12.

Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.

Aabye MG, Latorre I, Diaz J, Maldonado J, Mialdea I, Eugen-Olsen J, Ravn P, Dominguez J, Ruhwald M.

Eur Respir J. 2013 Aug;42(2):495-503. doi: 10.1183/09031936.00129412. Epub 2013 Jan 24.

13.

Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test.

Aabye MG, Hermansen TS, Ruhwald M, Praygod G, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Range N, Friis H, Changalucha J, Andersen AB, Ravn P.

BMC Infect Dis. 2012 Dec 27;12:379. doi: 10.1186/1471-2334-12-379.

14.

The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis.

Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Witte DR, Andersen AB, Friis H.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1680-5. doi: 10.5588/ijtld.12.0360.

PMID:
23131269
15.

[Research training is inadequate among future medical doctors].

Binderup ML, Ete NE, Ovesen C, Madsen MM, Andersen JB, Aabye MG.

Ugeskr Laeger. 2012 Oct 22;174(43):2624-7. Danish.

PMID:
23095651
16.

BCG protects against tuberculosis irrespective of HIV status: a matched case-control study in Mwanza, Tanzania.

Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Grewal HM, Changalucha J, Witte DR, Andersen AB, Friis H.

Thorax. 2013 Mar;68(3):288-9. doi: 10.1136/thoraxjnl-2012-201971. Epub 2012 Aug 24.

PMID:
22923459
17.

The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania.

Faurholt-Jepsen D, Range N, Praygod G, Kidola J, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Martinussen T, Krarup H, Witte DR, Andersen ÅB, Friis H.

BMC Infect Dis. 2012 Jul 27;12:165. doi: 10.1186/1471-2334-12-165.

18.

A simple method to quantitate IP-10 in dried blood and plasma spots.

Aabye MG, Eugen-Olsen J, Werlinrud AM, Holm LL, Tuuminen T, Ravn P, Ruhwald M.

PLoS One. 2012;7(6):e39228. doi: 10.1371/journal.pone.0039228. Epub 2012 Jun 27.

19.

The role of diabetes on the clinical manifestations of pulmonary tuberculosis.

Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Krarup H, Witte DR, Andersen AB, Friis H.

Trop Med Int Health. 2012 Jul;17(7):877-83. doi: 10.1111/j.1365-3156.2012.03002.x. Epub 2012 May 11.

20.

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.

Ruhwald M, Aabye MG, Ravn P.

Expert Rev Mol Diagn. 2012 Mar;12(2):175-87. doi: 10.1586/erm.11.97. Review.

PMID:
22369377
21.

Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania.

Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Pipper CB, Krarup H, Witte DR, Andersen AB, Friis H.

PLoS One. 2011;6(8):e24215. doi: 10.1371/journal.pone.0024215. Epub 2011 Aug 30.

22.

The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania.

PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HM, Magnussen P, Changalucha J, Andersen AB, Friis H.

Br J Nutr. 2012 Jan;107(2):263-71. doi: 10.1017/S0007114511002832. Epub 2011 Jul 6.

PMID:
21729372
23.

Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens.

Aabye MG, Ravn P, Johansen IS, Eugen-Olsen J, Ruhwald M.

Clin Vaccine Immunol. 2011 Jul;18(7):1150-6. doi: 10.1128/CVI.00051-11. Epub 2011 May 25.

24.

Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania.

PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HM, Magnussen P, Changalucha J, Andersen AB, Friis H.

J Nutr. 2011 Apr 1;141(4):685-91. doi: 10.3945/jn.110.131672. Epub 2011 Feb 23.

PMID:
21346105
25.

Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania.

PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HM, Magnussen P, Changalucha J, Andersen AB, Friis H.

Trans R Soc Trop Med Hyg. 2011 Mar;105(3):140-7. doi: 10.1016/j.trstmh.2010.11.009. Epub 2011 Jan 15.

PMID:
21239027
26.

Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients.

Aabye MG, Ruhwald M, Praygod G, Jeremiah K, Faurholt-Jepsen M, Faurholt-Jepsen D, Range N, Friis H, Changalucha J, Andersen AB, Ravn P.

Eur Respir J. 2010 Dec;36(6):1488-90. doi: 10.1183/09031936.00039010. No abstract available.

27.

The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, Faurholt D, Range N, Friis H, Changalucha J, Andersen AB.

PLoS One. 2009;4(1):e4220. doi: 10.1371/journal.pone.0004220. Epub 2009 Jan 19.

Supplemental Content

Support Center